Ondine Biomedical (UK) Today
| OBI Stock | 15.00 1.40 10.29% |
PerformanceGood
| Odds Of DistressQuite High
|
Ondine Biomedical is trading at 15.00 as of the 22nd of June 2025, a 10.29 percent increase since the beginning of the trading day. The stock's lowest day price was 13.5. Ondine Biomedical has more than 67 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 24th of March 2025 and ending today, the 22nd of June 2025. Click here to learn more.
Moving against Ondine Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Ondine Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ondine Biomedical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ondine Biomedical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Founder | CFA CFA |
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Ondine Biomedical (OBI) is traded on London Exchange in UK and employs 16 people. Ondine Biomedical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 66.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ondine Biomedical's market, we take the total number of its shares issued and multiply it by Ondine Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ondine Biomedical operates under Biotechnology sector and is part of Health Care industry. The entity has 443.43 M outstanding shares.
Ondine Biomedical generates negative cash flow from operations
Check Ondine Biomedical Probability Of Bankruptcy
Ownership AllocationOndine Biomedical owns a total of 443.43 Million outstanding shares. Ondine Biomedical has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Ondine Ownership Details
Ondine Biomedical Risk Profiles
Although Ondine Biomedical's alpha and beta are two of the key measurements used to evaluate Ondine Biomedical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.39 | |||
| Semi Deviation | 1.75 | |||
| Standard Deviation | 4.01 | |||
| Variance | 16.07 |
Ondine Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ondine Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Ondine Biomedical Corporate Executives
Elected by the shareholders, the Ondine Biomedical's board of directors comprises two types of representatives: Ondine Biomedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ondine. The board's role is to monitor Ondine Biomedical's management team and ensure that shareholders' interests are well served. Ondine Biomedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ondine Biomedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alan Thomas | NonBoard CFO | Profile | |
| Vipul Shah | VP CFO | Profile | |
| Michael Behlkeas | CFO COO | Profile |
Other Information on Investing in Ondine Stock
Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.